Active Hexose Correlated Compound promotes T helper (Th) 17 and 1 cell responses via inducing IL-1β production from monocytes in humans

Cellular Immunology

Volumn 275, Issue 1-2, 2012, Pages 19-23

  Lee, Won Woo ^a,b   Lee, Naeun ^a   Fujii, Hajime ^c   Kang, Insoo ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Seoul National University   (South Korea)

^c Amino Up Chemical Co   (Japan)

Author keywords

Cytokines; Monocytes; T helper cells

Indexed keywords

ACTIVE HEXOSE CORRELATED COMPOUND; CD4 ANTIGEN; GAMMA INTERFERON; HEXOSE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 17; INTERLEUKIN 1BETA; OLIGOSACCHARIDE; UNCLASSIFIED DRUG;

ARTICLE; BASIDIOMYCETES; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CROP; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; MONOCYTE; MUSHROOM; MYCELIUM; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH17 CELL;

BASIDIOMYCOTA; CELLS, CULTURED; HEXOSES; HUMANS; INTERLEUKIN-1BETA; MONOCYTES; OLIGOSACCHARIDES; TH1 CELLS; TH17 CELLS;

BASIDIOMYCOTA;

EID: 84860557616     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.04.001     Document Type: Article

References (28)

1. Zhu J., Yamane H., Paul W.E. Differentiation of effector CD4 T cell populations (*). Annu. Rev. Immunol. 2010, 28:445-489.
2. Reiner S.L. Development in motion: helper T cells at work. Cell 2007, 129:33-36.
3. Murphy K.M., Stockinger B. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat. Immunol. 2010, 11:674-680.
4. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 2009, 27:669-692.
5. Geissmann F., Auffray C., Palframan R., Wirrig C., Ciocca A., Campisi L., Narni-Mancinelli E., Lauvau G. Blood monocytes: distinct subsets, how they relate to dendritic cells and their possible roles in the regulation of T-cell responses. Immunol. Cell Biol. 2008, 86:398-408.
6. Gerosa F., Baldani-Guerra B., Lyakh L.A., Batoni G., Esin S., Winkler-Pickett R.T., Consolaro M.R., De Marchi M., Giachino D., Robbiano A., Astegiano M., Sambataro A., Kastelein R.A., Carra G., Trinchieri G. Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J. Exp. Med. 2008, 205:1447-1461.
7. Bittencourt V.C., Figueiredo R.T., da Silva R.B., Mourao-Sa D.S., Fernandez P.L., Sassaki G.L., Mulloy B., Bozza M.T., Barreto-Bergter E. An alpha-glucan of Pseudallescheria boydii is involved in fungal phagocytosis and Toll-like receptor activation. J. Biol. Chem. 2006, 281:22614-22623.
8. Estrada A., Yun C.H., Van Kessel A., Li B., Hauta S., Laarveld B. Immunomodulatory activities of oat beta-glucan in vitro and in vivo. Microbiol. Immunol. 1997, 41:991-998.
9. Nisini R., Torosantucci A., Romagnoli G., Chiani P., Donati S., Gagliardi M.C., Teloni R., Sargentini V., Mariotti S., Iorio E., Cassone A. Beta-Glucan of Candida albicans cell wall causes the subversion of human monocyte differentiation into dendritic cells. J. Leukoc. Biol. 2007, 82:1136-1142.
10. Hoshi H., Yagi Y., Iijima H., Matsunaga K., Ishihara Y., Yasuhara T. Isolation and characterization of a novel immunomodulatory alpha-glucan-protein complex from the mycelium of Tricholoma matsutake in Basidiomycetes. J. Agric. Food Chem. 2005, 53:8948-8956.
11. Ritz B.W. Supplementation with active hexose correlated compound increases survival following infectious challenge in mice. Nutr. Rev. 2008, 66:526-531.
12. Terakawa N., Matsui Y., Satoi S., Yanagimoto H., Takahashi K., Yamamoto T., Yamao J., Takai S., Kwon A.H., Kamiyama Y. Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial. Nutr. Cancer 2008, 60:643-651.
13. Ritz B.W., Nogusa S., Ackerman E.A., Gardner E.M. Supplementation with active hexose correlated compound increases the innate immune response of young mice to primary influenza infection. J. Nutr. 2006, 136:2868-2873.
14. Gao Y., Zhang D., Sun B., Fujii H., Kosuna K., Yin Z. Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses. Cancer Immunol. Immunother. 2006, 55:1258-1266.
15. + T cells producing interferon-gamma and/or tumor necrosis factor-alpha in healthy adults. Hum. Immunol. 2010, 71:1187-1190.
16. Lee W.W., Kang S.W., Choi J., Lee S.H., Shah K., Eynon E.E., Flavell R.A., Kang I. Regulating human Th17 cells via differential expression of IL-1 receptor. Blood 2010, 115:530-540.
17. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., Basham B., Smith K., Chen T., Morel F., Lecron J.C., Kastelein R.A., Cua D.J., McClanahan T.K., Bowman E.P., de Waal Malefyt R. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 2007, 8:950-957.
18. Acosta-Rodriguez E.V., Napolitani G., Lanzavecchia A., Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 2007, 8:942-949.
19. Aviles H., O'Donnell P., Orshal J., Fujii H., Sun B., Sonnenfeld G. Active hexose correlated compound activates immune function to decrease bacterial load in a murine model of intramuscular infection. Am. J. Surg. 2008, 195:537-545.
20. Aviles H., Belay T., Vance M., Sun B., Sonnenfeld G. Active hexose correlated compound enhances the immune function of mice in the hindlimb-unloading model of spaceflight conditions. J. Appl. Physiol. 2004, 97:1437-1444.
21. Gaffen S.L. An overview of IL-17 function and signaling. Cytokine 2008, 43:402-407.
22. Ye P. Requirement of interleukin-17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 2001, 194:519-527.
23. Conti H.R., Shen F., Nayyar N., Stocum E., Sun J.N., Lindemann M.J., Ho A.W., Hai J.H., Yu J.J., Jung J.W., Filler S.G., Masso-Welch P., Edgerton M., Gaffen S.L. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 2009, 206:299-311.
24. Huang W., Na L., Fidel P.L., Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 2004, 190:624-631.
25. Ishibashi H., Ikeda T., Tansho S., Ono Y., Yamazaki M., Sato A., Yamaoka K., Yamaguchi H., Abe S. Prophylactic efficacy of a Basidiomycetes preparation AHCC against lethal opportunistic infections in mice. Yakugaku Zasshi 2000, 120:715-719.
26. Joseph S.B., Miner K.T., Croft M. Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF. Eur. J. Immunol. 1998, 28:277-289.
27. Lamacchia C., Palmer G., Seemayer C.A., Talabot-Ayer D., Gabay C. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist. Arthritis Rheum. 2010, 62:452-462.
28. Wang S., Welte T., Fang H., Chang G.J., Born W.K., O'Brien R.L., Sun B., Fujii H., Kosuna K., Wang T. Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice. J. Nutr. 2009, 139:598-602.